Publication Raman spectroscopy reveals distinct differences between two closely related bacterial strains, Mycobacterium indicus pranii and Mycobacterium intracellulare. Verma T, Podder S, Mehta M, et al. Analytical and bioanalytical chemistry. 2019;
Publication Lipoarabinomannan from Mycobacterium indicus pranii shows immunostimulatory activity and induces autophagy in macrophages. Singh B, Saqib M, Chakraborty A, et al. PloS one. 2019; 14 (10) : e0224239. Download PDF
Publication Cell wall fraction of Mycobacterium indicus pranii shows potential Th1 adjuvant activity. Saqib M, Khatri R, Singh B, et al. International immunopharmacology. 2019;
Publication Mycobacterium indicus pranii protein MIP_05962 induces Th1 cell mediated immune response in mice. Sharma A, Saqib M, Sheikh JA, et al. International journal of medical microbiology : IJMM. 2018;
Publication Potential of adjunctive Mycobacterium w (MIP) immunotherapy in reducing the duration of standard chemotherapy against tuberculosis. Chahar M, Rawat KD, Reddy P V J, et al. The Indian journal of tuberculosis. 2018; 65 (4) : 335-344.
Publication Launching Of Immunization with the Vaccine Mycobacterium Indicus Pranii for Eradication of Leprosy in India Talwar G P, Jagdish GC. International Journal of Vaccine Research. 2017; Download PDF
Publication Development of a potent invigorator of immune responses endowed with both preventive and therapeutic properties. Talwar GP, Gupta JC, Mustafa AS, et al. Biologics : targets & therapy. 2017; Download PDF
Publication Making of an immuno therapeutic cum immuno prophylactic vaccine against leprosy endowed with multiple properties and useful applications Talwar G P, Zaheer S A, Gupta S, et al. Journal of medical discovery. 2017; 2 (4) : 1-8. Download PDF
Publication Gonadotropin and tumorigenesis: Direct and indirect effects on inflammatory and immunosuppressive mediators and invasion. Khare P, Bose A, Singh P, et al. Molecular carcinogenesis. 2017; 56 (2) : 359-370.
Publication Immunodominant protein MIP_05962 from Mycobacterium indicus pranii displays chaperone activity. Sharma A, Equbal M A, Pandey S, et al. The FEBS journal. 2017;
Publication Efficacy and Safety of Mycobacterium indicus pranii as an adjunct therapy in Category II pulmonary tuberculosis in a randomized trial. Sharma SK, Katoch K, Sarin R, et al. Scientific reports. 2017; 7 (1) : 3354. Download PDF
Publication Addition of immunotherapy to chemotherapy in pediatric borderline leprosy: a clinical evaluation Kamal R, M. N, R. D. International Journal of Contemporary Pediatrics. 2016; Download PDF
Publication Preparation, Characterization and in Vivo Antimycobacterial Studies of Panchovillin-Chitosan Nanocomposites. Rwegasila E, Mubofu EB, Nyandoro SS, et al. International journal of molecular sciences. 2016; Download PDF
Publication Cytotoxic and apoptotic effects of heat killed Mycobacterium indicus pranii (MIP) on various human cancer cell lines. Subramaniam M, In LL A, Kumar A, et al. Scientific reports. 2016; Download PDF
Publication Mycobacterium indicus pranii (Mw)-mediated protection against visceral leishmaniasis by reciprocal regulation of host dual-specificity phosphatases. Parveen S, Bandhyopadhyay S, Das S, et al. International immunology. 2016; 28 (12) : 585-595.
Publication Making of a highly useful multipurpose vaccine Talwar G, Singh P, Atrey N, et al. Journal of translational science. 2016; 1 (3) : 69-73. Download PDF
Publication Addition of Mycobacterium indicus pranii (MIP) vaccine as an immunotherapeutic with standard chemotherapy in borderline leprosy: A double blind study to assess clinical improvement (A preliminary report). Kamal R, Pathak V, Kumari A, et al. The British journal of dermatology. 2016;
Publication Generalized granulomatous dermatitis following Mycobacterium w (Mw) immunotherapy in lepromatous leprosy. Khullar G, Narang T, Nahar Saikia U, et al. Dermatologic therapy. 2016;
Publication The Progress of Therapeutic Vaccination with Regard to Tuberculosis. Cardona P. Frontiers in microbiology. 2016; Download PDF
